Health boost: New TB testing strategy improves diagnosi dailymaverick.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymaverick.co.za Daily Mail and Mail on Sunday newspapers.
Dr Limakatso Lebina (bottom row) presenting to CROI 2021.
Screening everyone with HIV and others at high risk of tuberculosis for active TB increased diagnosis rates by 17% compared to testing people who had potential symptoms of TB such as cough and fever, Dr Limakatso Lebina of the University of Witwatersrand reported to the 2021 virtual Conference on Retroviruses and Opportunistic Infections this week.
TB is under-diagnosed in people with HIV in sub-Saharan Africa, where it remains the biggest killer of people with HIV. Around 150,000 cases of TB are missed each year in South Africa – almost half the entire burden – and these people die or transmit TB to others before their illness is detected.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Global Pyrazinamide Market to Surpass US$ 163.1 Mn by 2027, Says Coherent Market Insights (CMI)
February 10, 2021 GMT
According to Coherent Market Insights, the Global Pyrazinamide Market is estimated to be valued at
US$ 143.9 Mn in 2020 and is expected to exhibit a CAGR of
4.6% during the forecast period (2020-2027).
Key Trends and Analysis of the Global Pyrazinamide Market:
ADVERTISEMENT
Tuberculosis accounts for the highest number of deaths, across the globe. For instance, according to the World Health Organization (WHO) factsheet 2018 on TB, globally 10.4 million people fell ill with TB in 2016 and 1.7 million people with TB died in the same year. Moreover, over 95% of TB deaths occur in low and middle-income economies. Deaths caused due to TB also include death of 0.4 million people infected with HIV. Such high number of patients across the world confirms the enormity of disea